Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group

Main objective of this study was to confirm that surgery alone is an effective and safe treatment for localised resectable neuroblastoma except stage 2 with amplified MYCN gene (MYCNA). Of 427 eligible stages 1–2 patients, 411 had normal MYCN and 16 had MYCNA. Of the 288 stage 1 patients with normal...

Descripción completa

Detalles Bibliográficos
Autores principales: De Bernardi, B, Mosseri, V, Rubie, H, Castel, V, Foot, A, Ladenstein, R, Laureys, G, Beck-Popovic, M, de Lacerda, A F, Pearson, A D J, De Kraker, J, Ambros, P F, de Rycke, Y, Conte, M, Bruzzi, P, Michon, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567095/
https://www.ncbi.nlm.nih.gov/pubmed/18766186
http://dx.doi.org/10.1038/sj.bjc.6604640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567095/
https://www.ncbi.nlm.nih.gov/pubmed/18766186
http://dx.doi.org/10.1038/sj.bjc.6604640

Ejemplares similares